| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.2 | 0.0001 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.14 | 0.006 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.099 | 0.07 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.089 | 0.1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.091 | 0.1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.087 | 0.2 |